Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Arnica Montana,Dimethyl Sulfone,Pyridoxine Hydrochloride
Therapeutic Area : Musculoskeletal
Study Phase : Approved FDF
Sponsor : Carlin Consumer Health
Deal Size : Undisclosed
Deal Type : Acquisition
Carlin Consumer Health Acquires Penetrex from Wellbeam Consumer Health
Details : Through the acquisition, Carlin expands its OTC portfolio with Penetrex, a formulation using natural ingredients like Arnica and Vitamin B6 for joint and muscle pain.
Product Name : Penetrex
Product Type : Other Large Molecule
Upfront Cash : Undisclosed
April 30, 2024
Lead Product(s) : Arnica Montana,Dimethyl Sulfone,Pyridoxine Hydrochloride
Therapeutic Area : Musculoskeletal
Highest Development Status : Approved FDF
Sponsor : Carlin Consumer Health
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : Arnica Montana
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : Ferndale Laboratories, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Large Molecule
Upfront Cash : Inapplicable
July 30, 2013
Lead Product(s) : Arnica Montana
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : Ferndale Laboratories, Inc.
Deal Size : Inapplicable
Deal Type : Inapplicable